

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.07385348 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.07385348 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.47907170 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.75519464 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72760718 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.72760718 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.00744746 |
| 8 | * response to type I interferon (GO:0034340) | 4.70469219 |
| 9 | * cellular response to type I interferon (GO:0071357) | 4.66442137 |
| 10 | * type I interferon signaling pathway (GO:0060337) | 4.66442137 |
| 11 | response to interferon-alpha (GO:0035455) | 4.13574470 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.04380274 |
| 13 | response to interferon-beta (GO:0035456) | 4.02870738 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.99912772 |
| 15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.93887324 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 3.91552876 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 3.86054101 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.83757444 |
| 19 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77406328 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74975213 |
| 21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72473710 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.70005752 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.69234592 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.66292093 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.63392022 |
| 26 | cellular response to interferon-beta (GO:0035458) | 3.58402959 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.58321577 |
| 28 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.52881584 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52810887 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52683504 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.45710606 |
| 32 | regulation of RIG-I signaling pathway (GO:0039535) | 3.41048439 |
| 33 | regulation of tolerance induction (GO:0002643) | 3.39418435 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37990996 |
| 35 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.34355172 |
| 36 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.34076765 |
| 37 | germinal center formation (GO:0002467) | 3.31821885 |
| 38 | tolerance induction (GO:0002507) | 3.31536792 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.31478591 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31302771 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29920466 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25703469 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.23071743 |
| 44 | defense response to protozoan (GO:0042832) | 3.22098658 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 3.21150366 |
| 46 | T cell migration (GO:0072678) | 3.20280702 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.19277458 |
| 48 | neutrophil activation (GO:0042119) | 3.19193930 |
| 49 | response to host immune response (GO:0052572) | 3.17334407 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17334407 |
| 51 | cellular extravasation (GO:0045123) | 3.11558268 |
| 52 | regulation of response to interferon-gamma (GO:0060330) | 3.10291618 |
| 53 | negative regulation of innate immune response (GO:0045824) | 3.09437805 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 3.09289110 |
| 55 | positive regulation of tolerance induction (GO:0002645) | 3.07764613 |
| 56 | response to protozoan (GO:0001562) | 3.07570992 |
| 57 | leukocyte aggregation (GO:0070486) | 3.06822464 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.03386304 |
| 59 | granulocyte activation (GO:0036230) | 3.02803840 |
| 60 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.01646172 |
| 61 | microglial cell activation (GO:0001774) | 3.00428215 |
| 62 | regulation of natural killer cell differentiation (GO:0032823) | 2.99177025 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99117167 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 2.99094467 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 2.98218503 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.97965576 |
| 67 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95696225 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94341119 |
| 69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92752083 |
| 70 | response to host (GO:0075136) | 2.92752083 |
| 71 | response to host defenses (GO:0052200) | 2.92752083 |
| 72 | negative regulation of viral genome replication (GO:0045071) | 2.91821329 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 2.91501988 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91456730 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90212724 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90051556 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90051556 |
| 78 | positive regulation of interferon-beta production (GO:0032728) | 2.89800798 |
| 79 | respiratory burst (GO:0045730) | 2.89761852 |
| 80 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.88614589 |
| 81 | negative thymic T cell selection (GO:0045060) | 2.88195633 |
| 82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.87829060 |
| 83 | response to interleukin-15 (GO:0070672) | 2.86298938 |
| 84 | B cell mediated immunity (GO:0019724) | 2.85870292 |
| 85 | negative T cell selection (GO:0043383) | 2.85824557 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.85517819 |
| 87 | macrophage activation (GO:0042116) | 2.84905487 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82724408 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 2.82724408 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82724408 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82724408 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82724408 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 2.82724408 |
| 94 | positive thymic T cell selection (GO:0045059) | 2.80765478 |
| 95 | B cell receptor signaling pathway (GO:0050853) | 2.79770166 |
| 96 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.78218274 |
| 97 | cellular response to exogenous dsRNA (GO:0071360) | 2.77202799 |
| 98 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.76509486 |
| 99 | detection of other organism (GO:0098543) | 2.76457957 |
| 100 | thymic T cell selection (GO:0045061) | 2.76313096 |
| 101 | T cell selection (GO:0045058) | 2.76012783 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.75149225 |
| 103 | regulation of type 2 immune response (GO:0002828) | 2.73648784 |
| 104 | negative regulation of type 2 immune response (GO:0002829) | 2.72389792 |
| 105 | negative regulation of B cell apoptotic process (GO:0002903) | 2.70731792 |
| 106 | mature B cell differentiation (GO:0002335) | 2.70642283 |
| 107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.69943593 |
| 108 | neutrophil activation involved in immune response (GO:0002283) | 2.69527214 |
| 109 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69089401 |
| 110 | positive regulation of humoral immune response (GO:0002922) | 2.68653632 |
| 111 | interferon-gamma production (GO:0032609) | 2.67407890 |
| 112 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66355548 |
| 113 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65939654 |
| 114 | detection of bacterium (GO:0016045) | 2.62277804 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61794305 |
| 116 | DNA deamination (GO:0045006) | 2.61074444 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.59672308 |
| 118 | mature B cell differentiation involved in immune response (GO:0002313) | 2.56381210 |
| 119 | response to peptidoglycan (GO:0032494) | 2.55357362 |
| 120 | cellular response to interleukin-15 (GO:0071350) | 2.54970196 |
| 121 | * cellular response to interferon-gamma (GO:0071346) | 2.53953500 |
| 122 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.51930114 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.51746792 |
| 124 | positive regulation of isotype switching (GO:0045830) | 2.51606399 |
| 125 | * defense response to virus (GO:0051607) | 2.51536666 |
| 126 | positive regulation of macrophage differentiation (GO:0045651) | 2.51250593 |
| 127 | dendritic cell chemotaxis (GO:0002407) | 2.51033392 |
| 128 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.50256346 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.50191964 |
| 130 | T cell homeostasis (GO:0043029) | 2.49649980 |
| 131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.48097772 |
| 132 | dendritic cell migration (GO:0036336) | 2.47831189 |
| 133 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.46909046 |
| 134 | positive regulation of B cell mediated immunity (GO:0002714) | 2.46909046 |
| 135 | cellular response to virus (GO:0098586) | 2.44387350 |
| 136 | regulation of B cell apoptotic process (GO:0002902) | 2.43368442 |
| 137 | mast cell activation (GO:0045576) | 2.43079386 |
| 138 | T-helper 1 type immune response (GO:0042088) | 2.42555291 |
| 139 | necroptotic process (GO:0070266) | 2.42368324 |
| 140 | * response to interferon-gamma (GO:0034341) | 2.41724839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.65078811 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.66213891 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53771968 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.49510159 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36952767 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77327867 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34649165 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16659123 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99810275 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85366469 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80280963 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68765920 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67122742 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64040568 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59942630 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54395576 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39771855 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35888568 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30046115 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24801196 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.18210363 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17426293 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14102565 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.08838521 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.07413316 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07384965 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05765542 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03901092 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99602883 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.96883414 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93080607 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86582887 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83157739 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81588703 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77680998 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77016048 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76497822 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75894393 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71943027 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71490638 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69599061 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67910308 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.67843630 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66862569 |
| 45 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60940823 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60215466 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.59464635 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58873004 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55748144 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55647580 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49700690 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49014131 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48086628 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47667183 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45806916 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42708868 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.40488943 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37045020 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36598952 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33462261 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31826020 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30866710 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30036893 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.28639368 |
| 65 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28554632 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28317034 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27273164 |
| 68 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27150154 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26971268 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26964732 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26102680 |
| 72 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24268226 |
| 73 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23755761 |
| 74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23179738 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22426569 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17844728 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16430067 |
| 78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14348149 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11336382 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11126211 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09700061 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08783817 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07439393 |
| 84 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06788631 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05736530 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05496166 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05076858 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04729264 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03132484 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02158779 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01747186 |
| 92 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99213423 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98979466 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98510033 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98049752 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97699848 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97655956 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92055542 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91341427 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91097931 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90815531 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90699440 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89420100 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88777881 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87012853 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86237573 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83680770 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83661261 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82480668 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82391710 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82227922 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81971688 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80260308 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.79700529 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79584548 |
| 116 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78725012 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78173262 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76625768 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74063483 |
| 120 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.68837022 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67971811 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67868651 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.67263709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.23921090 |
| 2 | MP0009785_altered_susceptibility_to | 3.38340841 |
| 3 | MP0000685_abnormal_immune_system | 3.29679705 |
| 4 | MP0003724_increased_susceptibility_to | 3.13538086 |
| 5 | MP0005671_abnormal_response_to | 3.05578044 |
| 6 | MP0003436_decreased_susceptibility_to | 2.84363567 |
| 7 | MP0001790_abnormal_immune_system | 2.81803323 |
| 8 | MP0005387_immune_system_phenotype | 2.81803323 |
| 9 | MP0001800_abnormal_humoral_immune | 2.70495146 |
| 10 | * MP0005025_abnormal_response_to | 2.68223395 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.61859788 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.58495938 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.56187727 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.47221905 |
| 15 | * MP0002723_abnormal_immune_serum | 2.41771846 |
| 16 | MP0002419_abnormal_innate_immunity | 2.29829964 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.25498355 |
| 18 | MP0001819_abnormal_immune_cell | 2.25165345 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.22848702 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.22739658 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.18511449 |
| 22 | MP0006082_CNS_inflammation | 2.03132754 |
| 23 | MP0001853_heart_inflammation | 1.98185631 |
| 24 | MP0002398_abnormal_bone_marrow | 1.97930057 |
| 25 | MP0003303_peritoneal_inflammation | 1.97414856 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.92912132 |
| 27 | MP0000716_abnormal_immune_system | 1.88472696 |
| 28 | MP0002405_respiratory_system_inflammati | 1.85012956 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.81738890 |
| 30 | MP0002006_tumorigenesis | 1.81580180 |
| 31 | MP0004947_skin_inflammation | 1.77486763 |
| 32 | MP0001873_stomach_inflammation | 1.76546594 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.76063775 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.76063775 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.73668628 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.73217721 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.65852051 |
| 38 | MP0002722_abnormal_immune_system | 1.64300774 |
| 39 | MP0008469_abnormal_protein_level | 1.63473795 |
| 40 | MP0002429_abnormal_blood_cell | 1.61337193 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.58040358 |
| 42 | MP0002254_reproductive_system_inflammat | 1.54547122 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.52496369 |
| 44 | MP0009764_decreased_sensitivity_to | 1.52452442 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.48078999 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.44984718 |
| 47 | MP0009278_abnormal_bone_marrow | 1.44272176 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.43828859 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.36487950 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.35107335 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.32200971 |
| 52 | MP0008260_abnormal_autophagy | 1.31471303 |
| 53 | MP0003866_abnormal_defecation | 1.28882310 |
| 54 | MP0005451_abnormal_body_composition | 1.27101457 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.24586334 |
| 56 | MP0005365_abnormal_bile_salt | 1.22508311 |
| 57 | MP0002933_joint_inflammation | 1.21803103 |
| 58 | MP0000858_altered_metastatic_potential | 1.19711981 |
| 59 | MP0004510_myositis | 1.17231418 |
| 60 | MP0005360_urolithiasis | 1.16218218 |
| 61 | MP0009840_abnormal_foam_cell | 1.14755883 |
| 62 | MP0000490_abnormal_crypts_of | 1.14432205 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.12178118 |
| 64 | MP0004883_abnormal_blood_vessel | 1.09466667 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.08322985 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.06908922 |
| 67 | MP0006054_spinal_hemorrhage | 1.06801238 |
| 68 | MP0000343_altered_response_to | 1.06323193 |
| 69 | MP0009763_increased_sensitivity_to | 1.06304960 |
| 70 | MP0000604_amyloidosis | 1.06060365 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.05235759 |
| 72 | MP0003045_fibrosis | 1.03053960 |
| 73 | MP0003448_altered_tumor_morphology | 1.02942716 |
| 74 | MP0003690_abnormal_glial_cell | 0.99249294 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.98002157 |
| 76 | MP0000609_abnormal_liver_physiology | 0.97678754 |
| 77 | MP0005164_abnormal_response_to | 0.97191066 |
| 78 | MP0005310_abnormal_salivary_gland | 0.96824526 |
| 79 | MP0002132_abnormal_respiratory_system | 0.95238765 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.93416473 |
| 81 | MP0003186_abnormal_redox_activity | 0.88071984 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87004375 |
| 83 | MP0005023_abnormal_wound_healing | 0.84686727 |
| 84 | MP0004381_abnormal_hair_follicle | 0.83507579 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.81525272 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.81315830 |
| 87 | MP0008004_abnormal_stomach_pH | 0.79545701 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.78033238 |
| 89 | MP0001851_eye_inflammation | 0.77707281 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.77236526 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.76982350 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.76491588 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.75969952 |
| 94 | MP0003075_altered_response_to | 0.75694023 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.75598269 |
| 96 | MP0003828_pulmonary_edema | 0.75161161 |
| 97 | MP0000598_abnormal_liver_morphology | 0.73999389 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.72972776 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.72586535 |
| 100 | MP0000249_abnormal_blood_vessel | 0.72331900 |
| 101 | MP0003252_abnormal_bile_duct | 0.70886686 |
| 102 | MP0008874_decreased_physiological_sensi | 0.70502828 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.69696114 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.68588111 |
| 105 | MP0003195_calcinosis | 0.67940598 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.67926970 |
| 107 | MP0005166_decreased_susceptibility_to | 0.67090512 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.66951686 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.66543602 |
| 110 | MP0005390_skeleton_phenotype | 0.66151044 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.65632957 |
| 112 | MP0001663_abnormal_digestive_system | 0.63747003 |
| 113 | MP0001764_abnormal_homeostasis | 0.63012366 |
| 114 | * MP0003795_abnormal_bone_structure | 0.62134832 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.61091521 |
| 116 | MP0003091_abnormal_cell_migration | 0.59332129 |
| 117 | MP0001542_abnormal_bone_strength | 0.59267500 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.59235326 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.56875370 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.55300138 |
| 121 | MP0005165_increased_susceptibility_to | 0.55099590 |
| 122 | MP0001958_emphysema | 0.54586102 |
| 123 | MP0003329_amyloid_beta_deposits | 0.52573511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.77964661 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.47551112 |
| 3 | Chronic otitis media (HP:0000389) | 4.44693855 |
| 4 | Myositis (HP:0100614) | 4.19712907 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.16877575 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.01282872 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.83166702 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.73928377 |
| 9 | Recurrent viral infections (HP:0004429) | 3.60977776 |
| 10 | Nasal polyposis (HP:0100582) | 3.58065630 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 3.57698233 |
| 12 | Thrombocytosis (HP:0001894) | 3.55540871 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.54344087 |
| 14 | IgM deficiency (HP:0002850) | 3.48679859 |
| 15 | Orchitis (HP:0100796) | 3.23454480 |
| 16 | Vasculitis (HP:0002633) | 3.13379223 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.10695866 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07365416 |
| 19 | Urticaria (HP:0001025) | 3.05848764 |
| 20 | Epistaxis (HP:0000421) | 2.95651091 |
| 21 | Neonatal hypoglycemia (HP:0001998) | 2.95509780 |
| 22 | Pustule (HP:0200039) | 2.95014203 |
| 23 | Abnormality of T cells (HP:0002843) | 2.94600634 |
| 24 | Prolonged bleeding time (HP:0003010) | 2.93596744 |
| 25 | Recurrent skin infections (HP:0001581) | 2.90625220 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 2.89517988 |
| 27 | Stomatitis (HP:0010280) | 2.87885560 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.87435055 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.85604345 |
| 30 | Optic neuritis (HP:0100653) | 2.85604345 |
| 31 | Abnormality of T cell number (HP:0011839) | 2.84852115 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84058975 |
| 33 | Autoimmune hemolytic anemia (HP:0001890) | 2.83199359 |
| 34 | Meningitis (HP:0001287) | 2.83055361 |
| 35 | Gingival bleeding (HP:0000225) | 2.81763939 |
| 36 | Petechiae (HP:0000967) | 2.80160414 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.79850468 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79067483 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79067483 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.78300629 |
| 41 | Chest pain (HP:0100749) | 2.77210186 |
| 42 | T lymphocytopenia (HP:0005403) | 2.75232836 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.75011062 |
| 44 | Agammaglobulinemia (HP:0004432) | 2.73117411 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.72563396 |
| 46 | Colitis (HP:0002583) | 2.71486497 |
| 47 | Increased IgE level (HP:0003212) | 2.70379982 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.69650918 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.68095444 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.65146324 |
| 51 | Chronic sinusitis (HP:0011109) | 2.63779595 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58577339 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58577339 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58577339 |
| 55 | IgG deficiency (HP:0004315) | 2.57859375 |
| 56 | Cellulitis (HP:0100658) | 2.57003975 |
| 57 | Long foot (HP:0001833) | 2.56193884 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.53164453 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.50751440 |
| 60 | Gangrene (HP:0100758) | 2.49833558 |
| 61 | Hypochromic anemia (HP:0001931) | 2.46793322 |
| 62 | Episodic fever (HP:0001954) | 2.45811802 |
| 63 | Joint hemorrhage (HP:0005261) | 2.44972603 |
| 64 | Increased IgM level (HP:0003496) | 2.44369552 |
| 65 | IgA deficiency (HP:0002720) | 2.43859576 |
| 66 | Encephalitis (HP:0002383) | 2.43562508 |
| 67 | Eosinophilia (HP:0001880) | 2.42910289 |
| 68 | Leukocytosis (HP:0001974) | 2.42416473 |
| 69 | Granulocytopenia (HP:0001913) | 2.41644409 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.40789333 |
| 71 | Acute myeloid leukemia (HP:0004808) | 2.39622234 |
| 72 | Joint swelling (HP:0001386) | 2.39379333 |
| 73 | Arterial thrombosis (HP:0004420) | 2.37961227 |
| 74 | Lymphopenia (HP:0001888) | 2.37868117 |
| 75 | Abnormal platelet function (HP:0011869) | 2.36714810 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.36714810 |
| 77 | Periodontitis (HP:0000704) | 2.36068608 |
| 78 | Anorexia (HP:0002039) | 2.35869081 |
| 79 | Hemoptysis (HP:0002105) | 2.34118308 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33612799 |
| 81 | Hematochezia (HP:0002573) | 2.32997950 |
| 82 | Loss of speech (HP:0002371) | 2.32588169 |
| 83 | Chronic diarrhea (HP:0002028) | 2.31543870 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.30559144 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.29584065 |
| 86 | Amyloidosis (HP:0011034) | 2.28458097 |
| 87 | Neoplasm of the adrenal cortex (HP:0100641) | 2.27829773 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.27793837 |
| 89 | B lymphocytopenia (HP:0010976) | 2.27793837 |
| 90 | Purpura (HP:0000979) | 2.27195116 |
| 91 | Prolonged partial thromboplastin time (HP:0003645) | 2.27090809 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.20367724 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.19259608 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.18550765 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 2.18208580 |
| 96 | Malnutrition (HP:0004395) | 2.17930106 |
| 97 | Bronchitis (HP:0012387) | 2.17504635 |
| 98 | Restrictive lung disease (HP:0002091) | 2.17045785 |
| 99 | Peritonitis (HP:0002586) | 2.15617361 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.12651379 |
| 101 | Gingivitis (HP:0000230) | 2.12208160 |
| 102 | Severe combined immunodeficiency (HP:0004430) | 2.11546886 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 2.11158201 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 2.10671600 |
| 105 | Increased serum ferritin (HP:0003281) | 2.10291489 |
| 106 | Abnormality of the pericardium (HP:0001697) | 2.09639067 |
| 107 | Recurrent sinusitis (HP:0011108) | 2.08638832 |
| 108 | Basal ganglia calcification (HP:0002135) | 2.08225423 |
| 109 | Abnormality of the prostate (HP:0008775) | 2.07800553 |
| 110 | Microcytic anemia (HP:0001935) | 2.06902249 |
| 111 | Emphysema (HP:0002097) | 2.06860658 |
| 112 | Premature loss of primary teeth (HP:0006323) | 2.06774018 |
| 113 | Arthralgia (HP:0002829) | 2.06385193 |
| 114 | Combined immunodeficiency (HP:0005387) | 2.05281634 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04905064 |
| 116 | Obstructive lung disease (HP:0006536) | 2.04905064 |
| 117 | Sepsis (HP:0100806) | 2.04037421 |
| 118 | Osteomyelitis (HP:0002754) | 2.01596533 |
| 119 | Keratoconjunctivitis (HP:0001096) | 2.00910050 |
| 120 | Skin rash (HP:0000988) | 2.00044926 |
| 121 | Polyneuropathy (HP:0001271) | 1.98857207 |
| 122 | Acne (HP:0001061) | 1.98840594 |
| 123 | Abnormality of the peritoneum (HP:0002585) | 1.98611658 |
| 124 | Skin ulcer (HP:0200042) | 1.97489128 |
| 125 | Myocardial infarction (HP:0001658) | 1.95455643 |
| 126 | Thyroiditis (HP:0100646) | 1.94035368 |
| 127 | Pulmonary embolism (HP:0002204) | 1.93284635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.86739766 |
| 2 | TYK2 | 3.41574292 |
| 3 | JAK3 | 2.91315969 |
| 4 | IKBKE | 2.84259217 |
| 5 | KIT | 2.78577544 |
| 6 | TBK1 | 2.76526485 |
| 7 | TXK | 2.65755780 |
| 8 | MAP3K14 | 2.52155489 |
| 9 | FGFR4 | 2.43718396 |
| 10 | BLK | 2.16766247 |
| 11 | ERN1 | 2.15981197 |
| 12 | IRAK4 | 2.15280546 |
| 13 | ZAP70 | 2.11568815 |
| 14 | JAK1 | 2.09874581 |
| 15 | TEC | 2.07599638 |
| 16 | STK16 | 1.98951792 |
| 17 | TGFBR2 | 1.98816156 |
| 18 | PRPF4B | 1.97490055 |
| 19 | NME2 | 1.92939797 |
| 20 | BTK | 1.90435725 |
| 21 | TNK2 | 1.84782713 |
| 22 | NLK | 1.83006365 |
| 23 | FLT3 | 1.82508727 |
| 24 | PRKG2 | 1.77979668 |
| 25 | IKBKB | 1.71960589 |
| 26 | CSF1R | 1.66208157 |
| 27 | IRAK3 | 1.60405233 |
| 28 | STK10 | 1.48704776 |
| 29 | MAPKAPK3 | 1.48703637 |
| 30 | KDR | 1.45223812 |
| 31 | FGFR3 | 1.42752381 |
| 32 | SYK | 1.37305404 |
| 33 | RPS6KA4 | 1.36838817 |
| 34 | FGR | 1.36806591 |
| 35 | TIE1 | 1.36299039 |
| 36 | PIM2 | 1.34602561 |
| 37 | EPHA3 | 1.33486916 |
| 38 | TAOK1 | 1.33333437 |
| 39 | TAOK3 | 1.29608679 |
| 40 | ITK | 1.28763178 |
| 41 | LCK | 1.28269808 |
| 42 | CSK | 1.20796032 |
| 43 | TGFBR1 | 1.20213409 |
| 44 | TESK2 | 1.18244570 |
| 45 | MAP3K10 | 1.14665509 |
| 46 | MAP2K3 | 1.11933535 |
| 47 | LRRK2 | 1.11690883 |
| 48 | MAP3K13 | 1.09425340 |
| 49 | NEK9 | 1.09227218 |
| 50 | CHUK | 1.06932674 |
| 51 | HCK | 1.06931609 |
| 52 | LYN | 1.06697507 |
| 53 | EPHB1 | 1.06196800 |
| 54 | MAP3K1 | 1.03793103 |
| 55 | GRK6 | 1.02213664 |
| 56 | TAOK2 | 1.01831252 |
| 57 | BMPR2 | 1.00828246 |
| 58 | PIM1 | 0.98998598 |
| 59 | MST4 | 0.98959429 |
| 60 | GRK7 | 0.98229257 |
| 61 | CDC42BPA | 0.97967621 |
| 62 | MAP3K12 | 0.95917765 |
| 63 | JAK2 | 0.90614491 |
| 64 | MATK | 0.87556815 |
| 65 | EEF2K | 0.84073626 |
| 66 | PRKD2 | 0.83019561 |
| 67 | MAP3K3 | 0.82697220 |
| 68 | PDK1 | 0.80534984 |
| 69 | RIPK1 | 0.80409478 |
| 70 | RIPK4 | 0.77833359 |
| 71 | TRIB3 | 0.76798019 |
| 72 | SIK1 | 0.74534355 |
| 73 | MAP2K6 | 0.72489434 |
| 74 | PTK2B | 0.70855267 |
| 75 | FES | 0.70077667 |
| 76 | MAPK7 | 0.69635025 |
| 77 | MARK2 | 0.69619771 |
| 78 | RPS6KB2 | 0.65148165 |
| 79 | MKNK2 | 0.62839836 |
| 80 | CLK1 | 0.62640101 |
| 81 | MAPK11 | 0.61897994 |
| 82 | PDPK1 | 0.61889295 |
| 83 | IRAK1 | 0.60176485 |
| 84 | SMG1 | 0.60109333 |
| 85 | HIPK2 | 0.58436464 |
| 86 | EIF2AK2 | 0.57986716 |
| 87 | MYLK | 0.57015699 |
| 88 | FYN | 0.56355983 |
| 89 | IRAK2 | 0.55223791 |
| 90 | YES1 | 0.54315741 |
| 91 | CAMKK1 | 0.52853361 |
| 92 | TRPM7 | 0.52517901 |
| 93 | BRSK2 | 0.52458212 |
| 94 | CAMKK2 | 0.52158317 |
| 95 | DAPK2 | 0.51667213 |
| 96 | PIK3CG | 0.51172982 |
| 97 | PTK6 | 0.48718943 |
| 98 | ACVR1B | 0.48217486 |
| 99 | MAPK4 | 0.48153520 |
| 100 | MAP3K2 | 0.47795577 |
| 101 | RPS6KA5 | 0.47378739 |
| 102 | MAP3K5 | 0.46356219 |
| 103 | KSR2 | 0.44972263 |
| 104 | MAP3K6 | 0.44887127 |
| 105 | MARK3 | 0.43717251 |
| 106 | MAP2K2 | 0.42858985 |
| 107 | BCKDK | 0.42220946 |
| 108 | MAPK15 | 0.41630162 |
| 109 | GRK1 | 0.41320263 |
| 110 | PRKCQ | 0.40808275 |
| 111 | INSRR | 0.38981535 |
| 112 | SIK2 | 0.38686245 |
| 113 | MAPKAPK2 | 0.38535291 |
| 114 | STK4 | 0.38176727 |
| 115 | MKNK1 | 0.38107179 |
| 116 | PRKCD | 0.37028763 |
| 117 | BMX | 0.36789059 |
| 118 | STK24 | 0.35740696 |
| 119 | SIK3 | 0.34768545 |
| 120 | ABL1 | 0.33894095 |
| 121 | RPS6KL1 | 0.33867702 |
| 122 | RPS6KC1 | 0.33867702 |
| 123 | ADRBK2 | 0.33448923 |
| 124 | RET | 0.32560748 |
| 125 | PKN2 | 0.31701582 |
| 126 | MAP3K11 | 0.31239765 |
| 127 | DYRK1B | 0.30255533 |
| 128 | CDK4 | 0.29132911 |
| 129 | IGF1R | 0.28862794 |
| 130 | MAPK12 | 0.27471342 |
| 131 | MAP3K7 | 0.27163995 |
| 132 | MAPK3 | 0.25081044 |
| 133 | TTN | 0.24587524 |
| 134 | EGFR | 0.24407679 |
| 135 | RPS6KA6 | 0.23970899 |
| 136 | PAK4 | 0.23585740 |
| 137 | CDK6 | 0.22741421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.33502368 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66744228 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.66273795 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55702601 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53839098 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51706654 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.46110176 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.41201162 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30976003 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11477357 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07418575 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.02212760 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98165148 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93383615 |
| 15 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.91561273 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81390483 |
| 17 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76783991 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75507646 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.72058788 |
| 20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.71371096 |
| 21 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68422608 |
| 22 | * Influenza A_Homo sapiens_hsa05164 | 1.63766656 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.60722487 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60409153 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.60317884 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.60027941 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54711397 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50266378 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49129955 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43184350 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.40534177 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39577340 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24900003 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22681724 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22505813 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22193163 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.21513140 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17397227 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.17177211 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.15635160 |
| 41 | * Hepatitis C_Homo sapiens_hsa05160 | 1.12607970 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.08544710 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07669012 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03669061 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99693084 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99632031 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99104627 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97774992 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.95698177 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.95135550 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.93795366 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.91865845 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.89747277 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86916369 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85141397 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81102518 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77238888 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76685560 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.75024542 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74757287 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74748381 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70903696 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70319377 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68825674 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68824022 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.68189215 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68138681 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.64708947 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62774314 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62485646 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62433384 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.61530515 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61502207 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59691213 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58438129 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.56783050 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.56641092 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56562934 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56480021 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55986708 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55407503 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55272490 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53220739 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52916521 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51006401 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50817447 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50356114 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49526981 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49492111 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.48420140 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48353015 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46990640 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44232741 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.43989892 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43659299 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43011147 |
| 97 | Proteasome_Homo sapiens_hsa03050 | 0.42523095 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41745840 |
| 99 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41590196 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41183055 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40823372 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39738896 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38756245 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.38716097 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38569772 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38381430 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38212111 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38099678 |
| 109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37278574 |
| 110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36909847 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36417616 |
| 112 | Mismatch repair_Homo sapiens_hsa03430 | 0.36163732 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35424828 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35404227 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34776975 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34599977 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34052677 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33534707 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33180238 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32006231 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31060929 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30986223 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29642308 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29150276 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28817365 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28129775 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27306742 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26404447 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24890535 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23000624 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22508061 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22085032 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20821818 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19520297 |

